Ólafsdóttir, A. F., Bolinder, J., Heise, T., Polonsky, W., Ekelund, M., Wijkman, M., . . . Lind, M. (2020). The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD‐5). Diabetes Obes Metab.
Citação norma ChicagoÓlafsdóttir, Arndís F., et al. "The Majority of People With Type 1 Diabetes and Multiple Daily Insulin Injections Benefit From Using Continuous Glucose Monitoring: An Analysis Based On the GOLD Randomized Trial (GOLD‐5)." Diabetes Obes Metab 2020.
Citação norma MLAÓlafsdóttir, Arndís F., et al. "The Majority of People With Type 1 Diabetes and Multiple Daily Insulin Injections Benefit From Using Continuous Glucose Monitoring: An Analysis Based On the GOLD Randomized Trial (GOLD‐5)." Diabetes Obes Metab 2020.